Ro and the NIA partner to create an Alzheimer’s disease registry for clinical trials
Direct-to-patient healthcare company Ro announced an agreement with the National Institute on Aging (NIA) to develop the Registry for Equal Access to Clinical Trials in Alzheimer’s Disease (REACT-AD). Ro will employ its telehealth platform to screen and recruit patients at elevated risk for developing Alzheimer’s disease (AD) or other related dementia to join REACT-AD for […]
Ro and the NIA partner to create an Alzheimer’s disease registry for clinical trials Read More ยป